COST- EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION FOR ADULTS AGED 60 YEARS AND OLDER IN PERU

被引：0
|
作者：
Figueroa, J. [1 ]
Owusu-Edusei, K. [2 ]
Valenzuela, G. [1 ]
Cossrow, N. [3 ]
Johnson, K. D. [3 ]
Parellada, C. [4 ]
机构：
[1] MSD Peru, Market Access, Lima, Peru
[2] Merck & Co Inc, Biostat Res Decis Sci BARDS, Rahway, NJ USA
[3] Merck & Co Inc, Ctr Observat & Real World Evidence, Rahway, NJ USA
[4] MSD Brazil, Ctr Observat & Realworld Evidence CORE Latin Amer, Sao Paulo, SP, Brazil
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE745
引用
收藏
页码：S198 / S198
页数：1
相关论文
共 50 条
  • [21] Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older
    Altawalbeh, Shoroq M.
    Wateska, Angela R.
    Nowalk, Mary Patricia
    Lin, Chyongchiou J.
    Harrison, Lee H.
    Schaffner, William
    Zimmerman, Richard K.
    Smith, Kenneth J.
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2024, 22 (01) : 61 - 71
  • [22] SOCIETAL COST OF RACIAL DISPARITIES IN PNEUMOCOCCAL DISEASE IN US ADULTS AGED 50 YEARS OR OLDER
    Altawalbeh, S.
    Wateska, A.
    Nowalk, M.
    Lin, C.
    Zimmerman, R.
    Smith, K.
    VALUE IN HEALTH, 2023, 26 (06) : S62 - S62
  • [23] The determinants of influenza vaccination effectiveness in adults aged 65 years and older: a systematic review
    Lim, W. W.
    Cowling, B. J.
    Chan, M. C. W.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 53 : 147 - 147
  • [24] Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older
    Shoroq M. Altawalbeh
    Angela R. Wateska
    Mary Patricia Nowalk
    Chyongchiou J. Lin
    Lee H. Harrison
    William Schaffner
    Richard K. Zimmerman
    Kenneth J. Smith
    Applied Health Economics and Health Policy, 2024, 22 : 61 - 71
  • [25] Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults
    Smith, Kenneth J.
    Nowalk, Mary Patricia
    Raymund, Mahlon
    Zimmerman, Richard K.
    VACCINE, 2013, 31 (37) : 3950 - 3956
  • [26] Cost-Effectiveness of Pneumococcal Vaccination and Uptake Improvement Programs in Underserved and General Population Adults Aged<65 Years
    Wateska, Angela R.
    Nowalk, Mary Patricia
    Lin, Chyongchiou J.
    Harrison, Lee H.
    Schaffner, William
    Zimmerman, Richard K.
    Smith, Kenneth J.
    JOURNAL OF COMMUNITY HEALTH, 2020, 45 (01) : 111 - 120
  • [27] Pneumococcal vaccination in older adults
    Hak, E
    Bonten, MJM
    Hoes, AW
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (07): : 712 - 713
  • [28] Falls in Mexican older adults aged 60 years and older
    Luis M Valderrama-Hinds
    Soham Al Snih
    Nai-wei Chen
    Martin A Rodriguez
    Rebeca Wong
    Aging Clinical and Experimental Research, 2018, 30 : 1345 - 1351
  • [29] Cost- Effectiveness Analysis of Pneumcoccal Vaccination in Iceland
    Bjoernsdottir, Margret
    LAEKNABLADID, 2010, 96 (09): : 537 - 543
  • [30] What do we know about the cost-effectiveness of pneumococcal conjugate vaccination in older adults?
    Newall, A. T.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (10) : 2666 - 2669
12345